The research subjects are to develop artificial catalytic systems that
can promote selective chemical reactions in cells leading to artificial
pseudo-life system and to establish new concept of medicine or curing
disease by using the artificial pseudo-life system.
One position is currently available for a top-level specialist (Postdoctoral fellow) who has much work experience in the field of molecular biology or biochemistry.
(Catalysis Medicine (Bio) Group Leader: Shigehiro Kawashima, Ph.D.)
For details, please refer JREC-IN website.
Our basketball team finally won the championship of basketball match held in pharmaceutical department ! Congratulations !
Keiichi Kaneko (D1) and Hideya Ikemoto (M1) received Poster Presentation Award at 3rd CSJ Chemistry Festa. Congratulations !
Dr. Atsuhiko Taniguchi (ERATO PD) received Good Stone Award (Young Oral Presentation Award) at APIPS 2013. Congratulations !
Novel N-oxyl radical catalyst developed by us, ketoABNO, is now commercialized by Wako pure chemical industry, Co., Ltd.(500mg: #016-25001, 1g: #012-25003)。ketoABNO is bench-stable, highly active catalyst for aerobic oxidation of amines and alcohols.
Tatsuhiko Yoshino(D3) attended 4th Otsu Conference as one of selected members.
ERATO KANAI Life Scicence Catalysis Project will launch in April, 2012. Official website is now open to access.
Please follow official Twitter of Kanai Laboratory !
New laboratory year has started ! New members and staffs have joined.